![](https://webarchive.library.unt.edu/eot2008/20090118123508im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 12: December 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123508im_/http://www.fda.gov/cder/graphics/pdf.gif)
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION; INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
>A> AN APOTEX CORP EQ 0.083% BASE;0.017% N77117 001 Dec 31, 2007 Dec NEWA
>A> AN BREATH LTD EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Dec NEWA
>A> AN IVAX PHARMS INC EQ 0.083% BASE;0.017% N76724 001 Dec 31, 2007 Dec NEWA
>A> AN NEPHRON EQ 0.083% BASE;0.017% N76749 001 Dec 31, 2007 Dec NEWA
>A> AN WATSON LABS EQ 0.083% BASE;0.017% N77559 001 Dec 31, 2007 Dec NEWA
BALSALAZIDE DISODIUM
CAPSULE; ORAL
>A> BALSALAZIDE DISODIUM
>A> AB APOTEX INC 750MG N77883 001 Dec 28, 2007 Dec NEWA
>A> AB MYLAN 750MG N77807 001 Dec 28, 2007 Dec NEWA
>A> AB ROXANE 750MG N77806 001 Dec 28, 2007 Dec NEWA
COLAZAL
>D> + SALIX PHARMS 750MG N20610 001 Jul 18, 2000 Dec CFTG
>A> AB + 750MG N20610 001 Jul 18, 2000 Dec CFTG
BLEOMYCIN SULFATE
INJECTABLE; INJECTION
BLEOMYCIN
>A> AP PHARMACHEMIE BV EQ 15 UNITS BASE/VIAL N65201 001 Dec 13, 2007 Dec NEWA
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
SENSORCAINE
>D> AP ABRAXIS 0.25% N18304 001 Dec CAHN
>D> AP 0.5% N18304 002 Dec CAHN
>D> AP 0.75% N18304 003 Dec CAHN
>A> AP APP PHARMS 0.25% N18304 001 Dec CAHN
>A> AP 0.5% N18304 002 Dec CAHN
>A> AP 0.75% N18304 003 Dec CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
SENSORCAINE
>D> AP ABRAXIS 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 Dec CAHN
>D> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 Dec CAHN
>A> AP APP PHARMS 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 Dec CAHN
>A> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 Dec CAHN
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL
BUSPIRONE HYDROCHLORIDE
>A> AB ACTAVIS TOTOWA 30MG N78302 001 Dec 17, 2007 Dec NEWA
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP + PHARMACHEMIE EQ 600MG/60ML (10MG/ML) N77269 004 Dec 28, 2007 Dec CRLD
CEFDINIR
CAPSULE; ORAL
CEFDINIR
>A> AB AUROBINDO 300MG N65434 001 Jan 07, 2008 Dec NEWA
FOR SUSPENSION; ORAL
CEFDINIR
>A> AB AUROBINDO 125MG/5ML N65473 001 Dec 14, 2007 Dec NEWA
>A> AB 250MG/5ML N65473 002 Dec 14, 2007 Dec NEWA
CEFTRIAXONE
INJECTABLE; IM-IV
CEFTRIAXONE
>A> AP HIKMA EQ 250MG BASE/VIAL N65342 001 Jan 10, 2008 Dec NEWA
>A> AP EQ 500MG BASE/VIAL N65342 002 Jan 10, 2008 Dec NEWA
>A> AP EQ 1GM BASE/VIAL N65342 003 Jan 10, 2008 Dec NEWA
>A> AP EQ 2GM BASE/VIAL N65342 004 Jan 10, 2008 Dec NEWA
CEPHALEXIN
CAPSULE; ORAL
CEPHALEXIN
>D> AB APOTHECON EQ 250MG BASE N63063 001 Sep 29, 1989 Dec DISC
>A> @ EQ 250MG BASE N63063 001 Sep 29, 1989 Dec DISC
>D> AB EQ 500MG BASE N63063 002 Sep 29, 1989 Dec DISC
>A> @ EQ 500MG BASE N63063 002 Sep 29, 1989 Dec DISC
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
NESACAINE
>D> + ABRAXIS 1% N09435 001 Dec CAHN
>D> AP 2% N09435 002 Dec CAHN
>A> + APP PHARMS 1% N09435 001 Dec CAHN
>A> AP 2% N09435 002 Dec CAHN
NESACAINE-MPF
>D> @ ABRAXIS 2% N09435 003 Dec CAHN
>D> AP + 2% N09435 006 May 02, 1996 Dec CAHN
>D> @ 3% N09435 004 Dec CAHN
>D> AP + 3% N09435 007 May 02, 1996 Dec CAHN
>A> @ APP PHARMS 2% N09435 003 Dec CAHN
>A> AP + 2% N09435 006 May 02, 1996 Dec CAHN
>A> @ 3% N09435 004 Dec CAHN
>A> AP + 3% N09435 007 May 02, 1996 Dec CAHN
CICLESONIDE
SPRAY, METERED; NASAL
OMNARIS
>D> + ALTANA PHARMA 0.05MG/INH N22004 001 Oct 20, 2006 Dec CAHN
>A> + NYCOMED US 0.05MG/INH N22004 001 Oct 20, 2006 Dec CAHN
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CIPROFLOXACIN EXTENDED RELEASE
>A> AB SANDOZ 212.6MG;EQ 287.5MG BASE N78712 001 Dec 11, 2007 Dec NEWA
DICLOFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC
>A> DICLOFENAC SODIUM
>A> AT BAUSCH AND LOMB 0.1% N78792 001 Dec 28, 2007 Dec NEWA
>A> AT NEXUS PHARMS 0.1% N78553 001 Dec 28, 2007 Dec NEWA
VOLTAREN
>D> + NOVARTIS 0.1% N20037 001 Mar 28, 1991 Dec CFTG
>A> AT + 0.1% N20037 001 Mar 28, 1991 Dec CFTG
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDIZEM CD
>D> AB3 BIOVAIL 120MG N20062 001 Aug 10, 1992 Dec CAHN
>A> AB3 120MG N20062 001 Aug 10, 1992 Dec CAHN
>D> AB3 180MG N20062 002 Dec 27, 1991 Dec CAHN
>A> AB3 180MG N20062 002 Dec 27, 1991 Dec CAHN
>D> AB3 240MG N20062 003 Dec 27, 1991 Dec CAHN
>A> AB3 240MG N20062 003 Dec 27, 1991 Dec CAHN
>D> AB3 300MG N20062 004 Dec 27, 1991 Dec CRLD
>A> AB3 + 300MG N20062 004 Dec 27, 1991 Dec CRLD
>D> BC + 360MG N20062 005 Aug 24, 1999 Dec CAHN
>A> BC + 360MG N20062 005 Aug 24, 1999 Dec CAHN
DILTIAZEM HYDROCHLORIDE
>D> AB3 BIOVAIL 120MG N20939 001 Jan 28, 2000 Dec DISC
>A> @ 120MG N20939 001 Jan 28, 2000 Dec DISC
>D> AB3 180MG N20939 002 Jan 28, 2000 Dec DISC
>A> @ 180MG N20939 002 Jan 28, 2000 Dec DISC
>D> AB3 240MG N20939 003 Jan 28, 2000 Dec DISC
>A> @ 240MG N20939 003 Jan 28, 2000 Dec DISC
>D> AB3 300MG N20939 004 Jan 28, 2000 Dec DISC
>A> @ 300MG N20939 004 Jan 28, 2000 Dec DISC
>A> @ 360MG N20939 005 Sep 14, 2001 Dec DISC
>A> @ 420MG N20939 006 Sep 14, 2001 Dec DISC
INJECTABLE; INJECTION
>D> CARDIZEM
>D> AP + BIOVAIL 100MG/VIAL N20792 001 Sep 05, 1997 Dec DISC
>A> @ 100MG/VIAL N20792 001 Sep 05, 1997 Dec DISC
DILTIAZEM HYDROCHLORIDE
>D> AP HOSPIRA 100MG/VIAL N75853 001 Dec 17, 2002 Dec CRLD
>A> + 100MG/VIAL N75853 001 Dec 17, 2002 Dec CRLD
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE W/ EPINEPHRINE
>D> AP + ABRAXIS 0.005MG/ML;0.5% N06488 012 Dec CAHN
>D> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Dec CAHN
>D> AP + 0.005MG/ML;1.5% N06488 017 Dec CAHN
>D> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Dec CAHN
>D> AP + 0.01MG/ML;1% N06488 004 Dec CAHN
>D> @ 0.01MG/ML;2% N06488 003 Dec CAHN
>D> @ 0.02MG/ML;2% N06488 005 Dec CAHN
>A> AP + APP PHARMS 0.005MG/ML;0.5% N06488 012 Dec CAHN
>A> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Dec CAHN
>A> AP + 0.005MG/ML;1.5% N06488 017 Dec CAHN
>A> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Dec CAHN
>A> AP + 0.01MG/ML;1% N06488 004 Dec CAHN
>A> @ 0.01MG/ML;2% N06488 003 Dec CAHN
>A> @ 0.02MG/ML;2% N06488 005 Dec CAHN
ETOPOSIDE
INJECTABLE; INJECTION
ETOPOSIDE
>A> AP ACCORD HLTHCARE 20MG/ML N74513 001 Mar 14, 1996 Dec CAHN
>D> AP SUPERGEN 20MG/ML N74513 001 Mar 14, 1996 Dec CAHN
FENOFIBRATE
TABLET; ORAL
TRIGLIDE
>D> BX SKYEPHARMA AG 160MG N21350 002 May 07, 2005 Dec CRLD
>A> BX + 160MG N21350 002 May 07, 2005 Dec CRLD
FLUVOXAMINE MALEATE
TABLET; ORAL
>A> LUVOX
>A> AB SOLVAY 25MG N21519 001 Dec 20, 2007 Dec NEWA
>A> AB 50MG N21519 002 Dec 20, 2007 Dec NEWA
>A> AB 100MG N21519 003 Dec 20, 2007 Dec NEWA
FOMEPIZOLE
INJECTABLE; INJECTION
ANTIZOL
>D> + JAZZ 1GM/ML N20696 001 Dec 04, 1997 Dec CFTG
>A> AP + 1.5GM/1.5ML (1GM/ML) N20696 001 Dec 04, 1997 Dec CFTG
>A> FOMEPIZOLE
>A> AP PHARMAFORCE 1.5GM/1.5ML (1GM/ML) N78368 001 Dec 14, 2007 Dec NEWA
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
TABLET; ORAL
AVANDARYL
>A> SB PHARMCO 2MG;8MG N21700 004 Mar 30, 2007 Dec NEWA
>A> 4MG;8MG N21700 005 Mar 30, 2007 Dec NEWA
GONADOTROPIN, CHORIONIC
INJECTABLE; INJECTION
CHORIONIC GONADOTROPIN
>D> @ ABRAXIS PHARM 5,000 UNITS/VIAL N17067 001 Dec CAHN
>D> AP + 10,000 UNITS/VIAL N17067 002 Dec CAHN
>D> @ 15,000 UNITS/VIAL N17067 004 Dec CAHN
>D> @ 20,000 UNITS/VIAL N17067 003 Dec CAHN
>A> @ APP PHARMS 5,000 UNITS/VIAL N17067 001 Dec CAHN
>A> AP + 10,000 UNITS/VIAL N17067 002 Dec CAHN
>A> @ 15,000 UNITS/VIAL N17067 004 Dec CAHN
>A> @ 20,000 UNITS/VIAL N17067 003 Dec CAHN
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION
>A> GRANISETRON HYDROCHLORIDE
>A> AP APOTEX CORP EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78197 001 Dec 31, 2007 Dec NEWA
>A> AP APP PHARMS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78522 001 Dec 31, 2007 Dec NEWA
>A> AP BAXTER HLTHCARE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N77177 001 Dec 31, 2007 Dec NEWA
>A> AP TEVA PARENTERAL EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78392 001 Dec 31, 2007 Dec NEWA
>A> AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) N77963 001 Jan 03, 2008 Dec NEWA
>A> AP WATSON LABS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78262 001 Dec 31, 2007 Dec NEWA
>A> GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
>A> AP TEVA PARENTERAL EQ 1MG BASE/ML (EQ 1MG BASE/ML) N77165 001 Dec 31, 2007 Dec NEWA
KYTRIL
>D> + ROCHE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N20239 003 Sep 17, 2004 Dec CFTG
>A> AP + EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N20239 003 Sep 17, 2004 Dec CFTG
>D> + EQ 1MG BASE/ML (EQ 1MG BASE/ML) N20239 004 Mar 11, 1994 Dec CFTG
>A> AP + EQ 1MG BASE/ML (EQ 1MG BASE/ML) N20239 004 Mar 11, 1994 Dec CFTG
>D> + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N20239 002 Mar 11, 1994 Dec CFTG
>A> AP + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N20239 002 Mar 11, 1994 Dec CFTG
TABLET; ORAL
>A> GRANISETRON HYDROCHLORIDE
>A> AB BARR EQ 1MG BASE N78221 001 Dec 31, 2007 Dec NEWA
>A> AB COREPHARMA EQ 1MG BASE N78260 001 Dec 31, 2007 Dec NEWA
>A> AB ROXANE EQ 1MG BASE N77842 001 Dec 31, 2007 Dec NEWA
>A> AB TEVA PHARMS EQ 1MG BASE N78080 001 Dec 31, 2007 Dec NEWA
KYTRIL
>D> + ROCHE EQ 1MG BASE N20305 001 Mar 16, 1995 Dec CFTG
>A> AB + EQ 1MG BASE N20305 001 Mar 16, 1995 Dec CFTG
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN SODIUM
>D> @ ABRAXIS PHARM 1,000 UNITS/ML N17651 005 Dec CAHN
>D> AP 1,000 UNITS/ML N17029 001 Dec CAHN
>D> AP 5,000 UNITS/ML N17651 006 Dec CAHN
>D> @ 5,000 UNITS/ML N17029 002 Dec CAHN
>D> @ 10,000 UNITS/ML N17651 003 Dec CAHN
>D> AP 10,000 UNITS/ML N17029 003 Dec CAHN
>D> @ 20,000 UNITS/ML N17651 008 Dec CAHN
>D> AP + 20,000 UNITS/ML N17029 004 Dec CAHN
>A> @ APP PHARMS 1,000 UNITS/ML N17651 005 Dec CAHN
>A> AP 1,000 UNITS/ML N17029 001 Dec CAHN
>A> AP 5,000 UNITS/ML N17651 006 Dec CAHN
>A> @ 5,000 UNITS/ML N17029 002 Dec CAHN
>A> @ 10,000 UNITS/ML N17651 003 Dec CAHN
>A> AP 10,000 UNITS/ML N17029 003 Dec CAHN
>A> @ 20,000 UNITS/ML N17651 008 Dec CAHN
>A> AP + 20,000 UNITS/ML N17029 004 Dec CAHN
>D> AP + BAXTER HLTHCARE 5,000 UNITS/0.5ML N17037 013 Apr 07, 1986 Dec DISC
>A> @ 5,000 UNITS/0.5ML N17037 013 Apr 07, 1986 Dec DISC
HEPARIN SODIUM IN PLASTIC CONTAINER
>D> AP ABRAXIS PHARM 1,000 UNITS/ML N17029 013 Dec 05, 1985 Dec CAHN
>D> AP 5,000 UNITS/ML N17029 014 Dec 05, 1985 Dec CAHN
>D> AP 10,000 UNITS/ML N17029 015 Dec 05, 1985 Dec CAHN
>D> AP 20,000 UNITS/ML N17029 016 Dec 05, 1985 Dec CAHN
>A> AP APP PHARMS 1,000 UNITS/ML N17029 013 Dec 05, 1985 Dec CAHN
>A> AP 5,000 UNITS/ML N17029 014 Dec 05, 1985 Dec CAHN
>A> AP 10,000 UNITS/ML N17029 015 Dec 05, 1985 Dec CAHN
>A> AP 20,000 UNITS/ML N17029 016 Dec 05, 1985 Dec CAHN
HEPARIN SODIUM PRESERVATIVE FREE
>D> AP + ABRAXIS PHARM 1,000 UNITS/ML N17029 010 Apr 28, 1986 Dec CAHN
>A> AP + APP PHARMS 1,000 UNITS/ML N17029 010 Apr 28, 1986 Dec CAHN
IBUPROFEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
>A> AB ACTAVIS ELIZABETH 400MG;5MG N78769 001 Jan 04, 2008 Dec NEWA
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION
CAMPTOSAR
>A> + PFIZER INC 20MG/ML N20571 001 Jun 14, 1996 Dec CAHN
>D> + PHARMACIA AND 20MG/ML N20571 001 Jun 14, 1996 Dec CAHN
ISOSORBIDE DINITRATE
TABLET; SUBLINGUAL
>D> ISORDIL
>D> AB BIOVAIL 2.5MG N12940 004 Jul 29, 1988 Dec DISC
>A> @ 2.5MG N12940 004 Jul 29, 1988 Dec DISC
>D> AB 5MG N12940 003 Jul 29, 1988 Dec DISC
>A> @ 5MG N12940 003 Jul 29, 1988 Dec DISC
>D> + 10MG N12940 005 Jul 29, 1988 Dec DISC
>A> @ 10MG N12940 005 Jul 29, 1988 Dec DISC
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION
LABETALOL HYDROCHLORIDE
>D> AP HOSPIRA 5MG/ML N75240 001 Nov 29, 1999 Dec CRLD
>A> AP + 5MG/ML N75240 001 Nov 29, 1999 Dec CRLD
>D> AP 5MG/ML N75239 001 Nov 29, 1999 Dec CRLD
>A> AP + 5MG/ML N75239 001 Nov 29, 1999 Dec CRLD
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> CARBOCAINE W/ NEO-COBEFRIN
>D> AP + EASTMAN KODAK 0.05MG/ML;2% N12125 002 Dec DISC
>A> @ 0.05MG/ML;2% N12125 002 Dec DISC
LEVONORGESTREL
TABLET; ORAL
PLAN B
>D> + DURAMED 0.75MG N21045 001 Jul 28, 1999 Dec DISC
>A> @ 0.75MG N21045 001 Jul 28, 1999 Dec DISC
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE
>D> AP + ABRAXIS 0.5% N06488 008 Dec CAHN
>D> AP + 1% N06488 007 Dec CAHN
>D> AP + 1.5% N06488 010 Dec CAHN
>D> @ 2% N06488 002 Dec CAHN
>A> AP + APP PHARMS 0.5% N06488 008 Dec CAHN
>A> AP + 1% N06488 007 Dec CAHN
>A> AP + 1.5% N06488 010 Dec CAHN
>A> @ 2% N06488 002 Dec CAHN
XYLOCAINE 4% PRESERVATIVE FREE
>D> AP + ABRAXIS 4% N10417 001 Dec CAHN
>A> AP + APP PHARMS 4% N10417 001 Dec CAHN
INJECTABLE; SPINAL
XYLOCAINE 1.5% W/ DEXTROSE 7.5%
>D> @ ABRAXIS 1.5% N16297 001 Dec CAHN
>A> @ APP PHARMS 1.5% N16297 001 Dec CAHN
JELLY; TOPICAL
XYLOCAINE
>D> AT + ABRAXIS 2% N08816 001 Dec CAHN
>A> AT + APP PHARMS 2% N08816 001 Dec CAHN
SOLUTION; ORAL
XYLOCAINE VISCOUS
>D> AT + ABRAXIS 2% N09470 001 Dec CAHN
>A> AT + APP PHARMS 2% N09470 001 Dec CAHN
SOLUTION; TOPICAL
XYLOCAINE 4% PRESERVATIVE FREE
>D> AT + ABRAXIS 4% N10417 002 Dec CAHN
>A> AT + APP PHARMS 4% N10417 002 Dec CAHN
LIDOCAINE; PRILOCAINE
CREAM; TOPICAL
EMLA
>D> AB + ABRAXIS 2.5%;2.5% N19941 001 Dec 30, 1992 Dec CAHN
>A> AB + APP PHARMS 2.5%;2.5% N19941 001 Dec 30, 1992 Dec CAHN
LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL
VYVANSE
>A> NEW RIVER PHARMS 20MG N21977 004 Dec 10, 2007 Dec NEWA
>A> 30MG N21977 001 Feb 23, 2007 Dec CAHN
>A> 40MG N21977 005 Dec 10, 2007 Dec NEWA
>A> 50MG N21977 002 Feb 23, 2007 Dec CAHN
>A> 60MG N21977 006 Dec 10, 2007 Dec NEWA
>A> + 70MG N21977 003 Feb 23, 2007 Dec CAHN
>D> SHIRE 30MG N21977 001 Feb 23, 2007 Dec CAHN
>D> 50MG N21977 002 Feb 23, 2007 Dec CAHN
>D> + 70MG N21977 003 Feb 23, 2007 Dec CAHN
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CARBOCAINE
>D> AP + EASTMAN KODAK 3% N12125 003 Dec DISC
>A> @ 3% N12125 003 Dec DISC
ISOCAINE HYDROCHLORIDE
>D> AP NOVOCOL 3% N80925 001 Dec CRLD
>A> AP + 3% N80925 001 Dec CRLD
SCANDONEST PLAIN
>D> AP DEPROCO 3% N88387 001 Oct 10, 1984 Dec CRLD
>A> AP + 3% N88387 001 Oct 10, 1984 Dec CRLD
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HYDROCHLORIDE
>A> AB INTERPHARM 500MG N78596 001 Jan 03, 2008 Dec NEWA
>A> AB 750MG N78596 002 Jan 03, 2008 Dec NEWA
METHIMAZOLE
TABLET; ORAL
METHIMAZOLE
>A> AB ACTAVIS TOTOWA 5MG N40734 001 Dec 14, 2007 Dec NEWA
>A> AB 10MG N40734 002 Dec 14, 2007 Dec NEWA
METRONIDAZOLE
CREAM; TOPICAL
METRONIDAZOLE
>A> AB G AND W LABS 0.75% N77549 001 Dec 19, 2007 Dec NEWA
MINOCYCLINE HYDROCHLORIDE
TABLET; ORAL
MINOCYCLINE HYDROCHLORIDE
>A> AB INDICUS PHARMA EQ 50MG BASE N65436 001 Dec 26, 2007 Dec NEWA
>A> AB EQ 75MG BASE N65436 002 Dec 26, 2007 Dec NEWA
>A> AB EQ 100MG BASE N65436 003 Dec 26, 2007 Dec NEWA
>A> NEBIVOLOL HYDROCHLORIDE
>A> TABLET; ORAL
>A> BYSTOLIC
>A> MYLAN BERTEK EQ 2.5MG BASE N21742 002 Dec 17, 2007 Dec NEWA
>A> EQ 5MG BASE N21742 003 Dec 17, 2007 Dec NEWA
>A> + EQ 10MG BASE N21742 004 Dec 17, 2007 Dec NEWA
NYSTATIN
CREAM; TOPICAL
MYCOSTATIN
>A> AT + BRISTOL MYERS 100,000 UNITS/GM N60575 001 Dec CAHN
>D> AT + RANBAXY 100,000 UNITS/GM N60575 001 Dec CAHN
POWDER; TOPICAL
MYCOSTATIN
>A> AT + BRISTOL MYERS 100,000 UNITS/GM N60578 001 Dec CAHN
>D> AT + RANBAXY 100,000 UNITS/GM N60578 001 Dec CAHN
TABLET; ORAL
>D> MYCOSTATIN
>D> AA + APOTHECON 500,000 UNITS N60574 001 Dec DISC
>A> @ BRISTOL MYERS 500,000 UNITS N60574 001 Dec DISC
OCTREOTIDE ACETATE
INJECTABLE; INJECTION
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
>D> AP BEDFORD EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Dec CRLD
>D> AP EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Dec CRLD
>D> AP EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Dec CRLD
OXCARBAZEPINE
TABLET; ORAL
OXCARBAZEPINE
>A> AB BRECKENRIDGE 150MG N78069 001 Jan 11, 2008 Dec NEWA
>A> AB 300MG N78069 002 Jan 11, 2008 Dec NEWA
>A> AB 600MG N78069 003 Jan 11, 2008 Dec NEWA
>A> AB TEVA PHARMS 150MG N78005 001 Dec 11, 2007 Dec NEWA
>A> AB 300MG N78005 002 Dec 11, 2007 Dec NEWA
>A> AB 600MG N78005 003 Dec 11, 2007 Dec NEWA
OXYTOCIN
INJECTABLE; INJECTION
OXYTOCIN
>D> AP + ABRAXIS PHARM 10USP UNITS/ML (10USP UNITS/ML) N18248 001 Dec CAHN
>D> + 100USP UNITS/10 ML (10USP UNITS/ML) N18248 002 Dec CAHN
>D> + 300USP UNITS/30 ML (10USP UNITS/ML) N18248 003 Jul 27, 2007 Dec CAHN
>A> AP + APP PHARMS 10USP UNITS/ML (10USP UNITS/ML) N18248 001 Dec CAHN
>A> + 100USP UNITS/10 ML (10USP UNITS/ML) N18248 002 Dec CAHN
>A> + 300USP UNITS/30 ML (10USP UNITS/ML) N18248 003 Jul 27, 2007 Dec CAHN
>D> @ BAXTER HLTHCARE 10USP UNITS/ML N18243 001 Dec CMFD
>A> AP + 10USP UNITS/ML (10USP UNITS/ML) N18243 001 Dec CMFD
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>A> AP EBEWE PHARMA 6MG/ML N78167 001 Dec 26, 2007 Dec NEWA
PAROMOMYCIN SULFATE
CAPSULE; ORAL
PAROMOMYCIN SULFATE
>A> AA X-GEN PHARMS EQ 250MG BASE N65173 001 Dec 14, 2007 Dec NEWA
PENTAMIDINE ISETHIONATE
FOR SOLUTION; INHALATION
NEBUPENT
>D> + ABRAXIS PHARM 300MG/VIAL N19887 001 Jun 15, 1989 Dec CAHN
>D> 600MG/VIAL N19887 002 Mar 22, 1996 Dec CAHN
>A> + APP PHARMS 300MG/VIAL N19887 001 Jun 15, 1989 Dec CAHN
>A> 600MG/VIAL N19887 002 Mar 22, 1996 Dec CAHN
INJECTABLE; INJECTION
PENTAM
>D> AP + ABRAXIS PHARM 300MG/VIAL N19264 001 Oct 16, 1984 Dec CAHN
>A> AP + APP PHARMS 300MG/VIAL N19264 001 Oct 16, 1984 Dec CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>D> @ LANNETT 30MG N87022 001 Feb 03, 1983 Dec CMFD
>A> AA 30MG N87022 001 Feb 03, 1983 Dec CMFD
PHENYTOIN SODIUM
CAPSULE; ORAL
DILANTIN
>D> + PARKE DAVIS 30MG EXTENDED N84349 001 Dec CTEC
>A> AB + 30MG EXTENDED N84349 001 Dec CTEC
EXTENDED PHENYTOIN SODIUM
>A> AB WOCKHARDT 30MG EXTENDED N40759 001 Dec 18, 2007 Dec NEWA
POLYMYXIN B SULFATE
INJECTABLE; INJECTION
POLYMXIN B SULFATE
>A> AP ABRAXIS PHARM EQ 500,000 U BASE/VIAL N65372 001 Jan 10, 2008 Dec NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB APOTEX 80MG N76341 004 Dec 28, 2007 Dec NEWA
>D> AB COBALT 10MG N76939 004 Oct 23, 2006 Dec CAHN
>D> AB 20MG N76939 003 Oct 23, 2006 Dec CAHN
>D> AB 40MG N76939 002 Oct 23, 2006 Dec CAHN
>A> AB COBALT LABS INC 10MG N76939 004 Oct 23, 2006 Dec CAHN
>A> AB 20MG N76939 003 Oct 23, 2006 Dec CAHN
>A> AB 40MG N76939 002 Oct 23, 2006 Dec CAHN
>A> AB 80MG N76939 001 Dec 28, 2007 Dec NEWA
>A> AB DR REDDYS LABS INC 80MG N76714 004 Dec 28, 2007 Dec NEWA
>A> AB GENPHARM 80MG N77013 004 Dec 28, 2007 Dec NEWA
>A> AB GLENMARK PHARMS 80MG N77987 004 Dec 28, 2007 Dec NEWA
>A> AB LUPIN PHARMS 10MG N77917 001 Jan 08, 2008 Dec NEWA
>A> AB 20MG N77917 002 Jan 08, 2008 Dec NEWA
>A> AB 40MG N77917 003 Jan 08, 2008 Dec NEWA
>A> AB 80MG N77917 004 Jan 08, 2008 Dec NEWA
PROPRANOLOL HYDROCHLORIDE
TABLET; ORAL
PROPRANOLOL HYDROCHLORIDE
>A> AB NORTHSTAR 10MG N78213 001 Jan 10, 2008 Dec NEWA
>A> AB 20MG N78213 002 Jan 10, 2008 Dec NEWA
>A> AB 40MG N78213 003 Jan 10, 2008 Dec NEWA
>A> AB 60MG N78213 004 Jan 10, 2008 Dec NEWA
>A> AB 80MG N78213 005 Jan 10, 2008 Dec NEWA
RAMIPRIL
CAPSULE; ORAL
ALTACE
>D> KING PHARMS 1.25MG N19901 001 Jan 28, 1991 Dec CTEC
>A> AB 1.25MG N19901 001 Jan 28, 1991 Dec CTEC
>D> 2.5MG N19901 002 Jan 28, 1991 Dec CTEC
>A> AB 2.5MG N19901 002 Jan 28, 1991 Dec CTEC
>D> 5MG N19901 003 Jan 28, 1991 Dec CTEC
>A> AB 5MG N19901 003 Jan 28, 1991 Dec CTEC
>D> + 10MG N19901 004 Jan 28, 1991 Dec CTEC
>A> AB + 10MG N19901 004 Jan 28, 1991 Dec CTEC
RAMIPRIL
>D> @ COBALT 1.25MG N76549 001 Oct 24, 2005 Dec CMFD
>A> AB 1.25MG N76549 001 Oct 24, 2005 Dec CMFD
>D> @ 2.5MG N76549 002 Oct 24, 2005 Dec CMFD
>A> AB 2.5MG N76549 002 Oct 24, 2005 Dec CMFD
>D> @ 5MG N76549 003 Oct 24, 2005 Dec CMFD
>A> AB 5MG N76549 003 Oct 24, 2005 Dec CMFD
>D> @ 10MG N76549 004 Oct 24, 2005 Dec CMFD
>A> AB 10MG N76549 004 Oct 24, 2005 Dec CMFD
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
RANITIDINE HYDROCHLORIDE
>A> AA RANBAXY EQ 15MG BASE/ML N78448 001 Dec 13, 2007 Dec NEWA
RIVASTIGMINE TARTRATE
CAPSULE; ORAL
RIVASTIGMINE TARTRATE
>A> AB WATSON LABS EQ 1.5MG BASE N77129 001 Jan 08, 2008 Dec NEWA
>A> AB EQ 3MG BASE N77129 002 Jan 08, 2008 Dec NEWA
>A> AB EQ 4.5MG BASE N77129 003 Jan 08, 2008 Dec NEWA
>A> AB EQ 6MG BASE N77129 004 Jan 08, 2008 Dec NEWA
>A> SAPROPTERIN DIHYDROCHLORIDE
>A> TABLET; ORAL
>A> KUVAN
>A> + BIOMARIN PHARM 100MG N22181 001 Dec 13, 2007 Dec NEWA
SERTRALINE HYDROCHLORIDE
TABLET; ORAL
SERTRALINE HYDROCHLORIDE
>A> AB WOCKHARDT EQ 25MG BASE N78403 001 Jan 08, 2008 Dec NEWA
>A> AB EQ 50MG BASE N78403 002 Jan 08, 2008 Dec NEWA
>A> AB EQ 100MG BASE N78403 003 Jan 08, 2008 Dec NEWA
TERBUTALINE SULFATE
INJECTABLE; INJECTION
TERBUTALINE SULFATE
>A> AP AKORN 1MG/ML N78151 001 Jan 07, 2008 Dec NEWA
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION
AGGRASTAT
>A> MEDICURE EQ 5MG BASE/100ML (EQ 0.05MG N20913 002 May 17, 2002 Dec NEWA
>A> + EQ 12.5MG BASE/250ML (EQ 0.05MG N20913 003 Apr 20, 2000 Dec NEWA
>D> + EQ 0.25MG BASE/ML N20912 001 May 14, 1998 Dec CPOT
>A> + EQ 12.5MG BASE/50ML (EQ 0.25MG N20912 001 May 14, 1998 Dec CPOT
>D> + EQ 0.05MG BASE/ML N20913 001 May 14, 1998 Dec DISC
>A> @ EQ 25MG BASE/500ML (EQ 0.05MG N20913 001 May 14, 1998 Dec DISC
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
ZANAFLEX
>D> AB ACORDA EQ 2MG BASE N20397 002 Feb 04, 2000 Dec DISC
>A> @ EQ 2MG BASE N20397 002 Feb 04, 2000 Dec DISC
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
TOBRAMYCIN
>D> ABRAXIS PHARM EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Dec CAHN
>A> APP PHARMS EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Dec CAHN
CETIRIZINE HYDROCHLORIDE
TABLET; ORAL
CETIRIZINE HYDROCHLORIDE
>A> CARACO 5MG N77631 001 Jan 11, 2008 Dec NEWA
>A> 10MG N77631 002 Jan 11, 2008 Dec NEWA
CETIRIZINE HYDROCHLORIDE ALLERGY
>A> ACTAVIS ELIZABETH 5MG N78615 003 Dec 28, 2007 Dec NEWA
>A> 10MG N78615 004 Dec 28, 2007 Dec NEWA
>A> APOTEX INC 5MG N78317 001 Dec 27, 2007 Dec NEWA
>A> 10MG N78317 002 Dec 27, 2007 Dec NEWA
>A> CARACO 5MG N77499 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77499 002 Dec 27, 2007 Dec NEWA
>A> MYLAN 5MG N76677 001 Dec 27, 2007 Dec NEWA
>A> 10MG N76677 002 Dec 27, 2007 Dec NEWA
>A> PAR PHARM 5MG N76047 001 Dec 27, 2007 Dec NEWA
>A> 10MG N76047 002 Dec 27, 2007 Dec NEWA
>A> PERRIGO R AND D 5MG N78336 001 Dec 27, 2007 Dec NEWA
>A> 10MG N78336 002 Dec 27, 2007 Dec NEWA
>A> RANBAXY 5MG N77498 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77498 002 Dec 27, 2007 Dec NEWA
>A> SANDOZ 5MG N77946 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77946 002 Dec 27, 2007 Dec NEWA
>A> WOCKHARDT 5MG N78427 003 Dec 28, 2007 Dec NEWA
>A> 10MG N78427 004 Dec 28, 2007 Dec NEWA
CETIRIZINE HYDROCHLORIDE HIVES
>A> ACTAVIS ELIZABETH 5MG N78615 001 Dec 28, 2007 Dec NEWA
>A> 10MG N78615 002 Dec 28, 2007 Dec NEWA
>A> APOTEX INC 5MG N78317 003 Dec 27, 2007 Dec NEWA
>A> 10MG N78317 004 Dec 27, 2007 Dec NEWA
>A> CARACO 5MG N77499 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77499 004 Dec 27, 2007 Dec NEWA
>A> MYLAN 5MG N76677 004 Dec 27, 2007 Dec NEWA
>A> 10MG N76677 003 Dec 27, 2007 Dec NEWA
>A> PAR PHARM 5MG N76047 003 Dec 27, 2007 Dec NEWA
>A> 10MG N76047 004 Dec 27, 2007 Dec NEWA
>A> PERRIGO R AND D 5MG N78336 003 Dec 27, 2007 Dec NEWA
>A> 10MG N78336 004 Dec 27, 2007 Dec NEWA
>A> RANBAXY 5MG N77498 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77498 004 Dec 27, 2007 Dec NEWA
>A> SANDOZ 5MG N77946 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77946 004 Dec 27, 2007 Dec NEWA
>A> WOCKHARDT 5MG N78427 001 Dec 28, 2007 Dec NEWA
>A> 10MG N78427 002 Dec 28, 2007 Dec NEWA
FAMOTIDINE
TABLET, CHEWABLE; ORAL
PEPCID AC
>A> MERCK 20MG N20801 002 Dec 17, 2007 Dec NEWA
>A> OMEPRAZOLE
>A> TABLET, DELAYED RELEASE; ORAL
>A> OMEPRAZOLE
>A> + DEXCEL PHARMA 20MG N22032 001 Dec 04, 2007 Dec NEWA
Back
to Top
Back to Additions/Deletions Index
Date created: January 11, 2008 |
![](https://webarchive.library.unt.edu/eot2008/20090118123508im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |